38 results
6-K
BYSI
BeyondSpring Inc
10 Jan 24
Current report (foreign)
3:00pm
or procedure, which disagreements, if not resolved to the satisfaction of EY, would have caused EY to make reference to the subject matter
6-K
EX-99.2
1o5fml69a7iu8c4pj5cs
9 Feb 21
Current report (foreign)
9:21am
6-K
EX-1.1
0av321fsu8wucq
23 Nov 20
Current report (foreign)
4:16pm
424B5
2kmjr1 r5kj
19 Nov 20
Prospectus supplement for primary offering
4:12pm
424B5
45p7d8
17 Nov 20
Prospectus supplement for primary offering
4:19pm
6-K
nssn07urckod4xg0y
13 Nov 20
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
7:28am
6-K
sjo6muq1x
23 Jun 20
Current report (foreign)
4:09pm
6-K
EX-1.1
byz7v cpu
23 Jun 20
Current report (foreign)
4:09pm
424B5
66emarzrj 4u
19 Jun 20
Prospectus supplement for primary offering
4:31pm
424B5
v3u08zeq
18 Jun 20
Prospectus supplement for primary offering
4:40pm
6-K
EX-1.1
9zqklp13x9yjayw3
29 Oct 19
Current report (foreign)
4:05pm
424B5
ch4u8kwdmpv02bzyn1
28 Oct 19
Prospectus supplement for primary offering
4:02pm